AN UNWAVERING COMMITMENT TO ENABLING LIFE-SAVING PHARMACEUTICALS
For over 40 years, we’ve been supplying industry-leading, plant-based excipients and raw materials. Our expertise and technical resources are never far away, with three innovation centers of excellence located worldwide (France, U.S., and Singapore). We continually evolve our service offering to meet our customer demands.
From oral dosage drug product formulations including nutraceuticals, to injectables and dialysis solutions and biopharma materials, we hold ourselves to the highest industry standards – providing consistency and reliability across every ingredient.
Our legacy: Technical expertise is empowered by our diverse global Research and Development network. For years, Roquette has been the market and technical leader in starches and polyols, with over 60 patents and new product launches. Now we are expanding to other excipient chemistries to provide unique solutions to the technical challenges you face.
Our mission: to provide technical expertise to all stages of pharmaceutical development, to instill in our customers a sense of confidence by delivering world-class ingredients and raw materials, and to remain consistent in our ability to help customers develop and elevate life-saving pharmaceuticals.
Uncompromised quality standards supported by complete supply chain traceability. Industry-leading innovation backed by a legacy of expertise. An unwavering commitment to enabling life-saving pharmaceuticals.
Contact Details:
Company name: Roquette
Website: www.roquette.com/pharma
Stand/Booth number: 10.2A70
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
